▶ Myfina Tab.
▶Manufacturer: Ilhwa Co., Ltd.
▶Sold by: Ilhwa Co., Ltd.
▶Insurance code : 640902720
▶Storage : Airtight, light-resistant container, store at room temperature (1~30℃)
This item has been added to your cart.
Should I order it along with the items in my shopping cart?
+ Appearance
Blue circular film-coated tablet
+ Active ingredient(s)
finastreid 5mg
+ Administration and dose
Administer 1 tablet (5mg) once a day regardless of meals.
At least 6 months of therapy is necessary even if symptoms are improved after administration.
- Renal failure: As there are no pharmacokinetic changes when this drug is administered, there is no need to adjust dose for various types of renal failure patients (creatinine clearance of 9ml/min).
- Administration to elderly patients: While excretion of this drug is slightly reduced in elderly patients of 70 years or older, dose adjustment is not necessary.
+ Indications
Treatment of benign prostatic hyperplasia : degeneration of thickened prostate, improvement of urinary flow, improvement of symptoms of benign prostatic hyperplasia, reduced frequency of acute urinary retention, reduced need for surgery such as transurethral resection of the prostate and prostate resection+ Appearance
Blue circular film-coated tablet
+ Active ingredient(s)
finastreid 5mg
+ Administration and dose
Administer 1 tablet (5mg) once a day regardless of meals.
At least 6 months of therapy is necessary even if symptoms are improved after administration.
- Renal failure: As there are no pharmacokinetic changes when this drug is administered, there is no need to adjust dose for various types of renal failure patients (creatinine clearance of 9ml/min).
- Administration to elderly patients: While excretion of this drug is slightly reduced in elderly patients of 70 years or older, dose adjustment is not necessary.
+ Indications
Treatment of benign prostatic hyperplasia : degeneration of thickened prostate, improvement of urinary flow, improvement of symptoms of benign prostatic hyperplasia, reduced frequency of acute urinary retention, reduced need for surgery such as transurethral resection of the prostate and prostate resection